Treatment for Mammogram

Phase-Based Progress Estimates
35 - 100
What conditions do you have?

Study Summary

This trial will test how safe and effective a new breast cancer screening device is, and if it is useful for diagnosis.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: 4 years

4 years
Clinically acceptable image quality of the Investigational Device.
Mammograms can be safety acquired on the Investigational Device.
Subject assessment of comfort of the Investigational Device.
The ease of positioning and usability of the Investigational Device.

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

5400 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 years

Who is running the clinical trial?

Hologic, Inc.Lead Sponsor
45 Previous Clinical Trials
52,450 Total Patients Enrolled

Eligibility Criteria

Age 35 - 100 · Female Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a female of any race or ethnicity.
You are a minimum of 35 years old.
The individual is recommended for a screening or diagnostic mammogram, or breast biopsy.